0001225208-22-003465.txt : 20220225
0001225208-22-003465.hdr.sgml : 20220225
20220225174638
ACCESSION NUMBER: 0001225208-22-003465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220223
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAMICO JENNIFER B.
CENTRAL INDEX KEY: 0001805617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 22682516
MAIL ADDRESS:
STREET 1: C/O PFIZER INC. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2022-02-23
0000078003
PFIZER INC
PFE
0001805617
DAMICO JENNIFER B.
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
SVP & Controller
Common Stock
2022-02-23
4
M
0
11748.0000
27.3400
A
21668.0000
D
Common Stock
2022-02-23
4
F
0
2339.0000
46.8700
D
19329.0000
D
Common Stock
2022-02-23
4
F
0
5815.0000
51.2800
D
13514.0000
D
Common Stock
2022-02-24
4
A
0
2893.0000
0.0000
A
16407.0000
D
Stock Appreciation Rights
27.3400
2022-02-23
4
M
0
11748.0000
0.0000
D
2022-02-23
2022-02-23
Common Stock
11748.0000
0.0000
D
Stock Appreciation Rights
45.9600
2022-02-24
4
A
0
11623.0000
0.0000
A
2027-02-24
2027-02-24
Common Stock
11623.0000
11623.0000
D
Stock Appreciation Rights
45.9600
2022-02-24
4
A
0
10222.0000
0.0000
A
2029-02-24
2029-02-24
Common Stock
10222.0000
10222.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Jennifer B. Damico
2022-02-25